Reframe Daily: Fish oil helps burn patients heal faster, new probiotic spray eases BV, and mice beat type 1 diabetes

Reframe Daily—curated by Christin Chong (neuroscience PhD, Buddhist chaplain, healthtech strategy consultant)—delivers optimistic and credible health research updates you won’t find in most popular news outlets, from sources scientists and healthcare providers read and trust.

Today in one sentence: Fish oil supplements helped people with severe burns control inflammation and blood sugar, an early-psychosis care program lowered the chance of developing schizophrenia, a vaginal Bacillus spray reduced BV symptoms and bad bugs, combining surgical microwave ablation with dual immunotherapy slowed advanced pancreatic cancer, and a chemo-free antibody transplant strategy cured autoimmune type 1 diabetes in mice.

Pop in the Discord to chat about health →
https://forms.gle/tN3oabFTsDF21VnS8

Personal shares from Christin here →
http://christin.substack.com/

Good news: Fish oil (rich in EPA) helped calm inflammation and keep blood sugar steadier in people with serious burns in a randomized clinical trial.

Eicosapentaenoic acid decreases inflammation and improves glucose homeostasis in patients with burns: a randomized clinical trial

Market readiness: 🙂🙂🙂🙂🙂 (fish‑oil supplements are already OTC in the US; this small hospital RCT suggests a use clinicians could consider now while larger trials replicate). 

Good news: An early‑care program for first‑episode psychosis cut the chance of developing schizophrenia by ~39% over 2 years versus usual care in a randomized trial.

Transition rates to schizophrenia and early intervention effectiveness in substance‑induced and brief psychotic disorders: a randomized controlled trial

Market readiness: 🙂🙂🙂🙂 (the components—family education, CBT, low‑dose antipsychotic with monitoring—already exist in US clinics; the exact protocol needs local adaptation and replication). 

Good news: A vaginal‑spray probiotic (Bacillus spores) added to standard care improved symptoms and reduced harmful bacteria for bacterial vaginosis in a double‑blind, randomized pilot study.

Vaginal‑spray Bacillus spore probiotics as a potential treatment and reducing recurrence of bacterial vaginosis: randomized, double‑blind, and controlled pilot study

Market readiness: 🙂🙂 (human RCT signal, but it’s a small pilot and the specific spray isn’t cleared/marketed in the US; needs larger confirmatory trials). 

Good news: For patients with unresectable, locally advanced pancreatic cancer, combining surgical microwave ablation with dual immunotherapy showed encouraging progression‑free survival in an early phase‑2 clinical study.

Progression‑free survival for unresectable non‑metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase‑2 non‑randomized prospective clinical trial

Market readiness: 🙂🙂 (promising early‑phase signal; all components exist clinically, but this combined approach is off‑label and needs randomized trials before broad adoption). 

Good news: In mice with autoimmune type 1 diabetes, a chemo‑free antibody conditioning plus blood‑ and islet‑cell transplants restored immune tolerance and reversed diabetes without chronic immunosuppression.

Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody‑based conditioning

Market readiness: 🙂 (preclinical—success in mice; will require extensive safety and efficacy testing in humans). 

Thank you for taking the time to take care of yourself and your loved ones.